These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 15093546)

  • 1. Vaccines for the prevention of diseases caused by potential bioweapons.
    Hassani M; Patel MC; Pirofski LA
    Clin Immunol; 2004 Apr; 111(1):1-15. PubMed ID: 15093546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preventive vaccines against bioterrorism: evaluation of efficacy and safety.
    Horne AD; Clifford J; Goldenthal KL; Kleppinger C; Lachenbruch PA
    Vaccine; 2004 Nov; 23(1):84-90. PubMed ID: 15519711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioterror, agroterror, and new diseases.
    Ambrus JL; Ambrus CM; Ambrus JL; Akhter S; Zaidi S; Rohilla R; Baig MS
    Discov Med; 2007 Jun; 7(38):82-7. PubMed ID: 18093470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioterrorism: a new frontier for drug discovery and development.
    Shailubhai K
    IDrugs; 2003 Aug; 6(8):773-80. PubMed ID: 12917773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current methods for the rapid diagnosis of bioterrorism-related infectious agents.
    Fan J; Kraft AJ; Henrickson KJ
    Pediatr Clin North Am; 2006 Oct; 53(5):817-42, vii-viii. PubMed ID: 17027612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioterrorism: what level is the threat and are vaccines the answer?
    Smith LA
    Expert Rev Vaccines; 2004 Oct; 3(5):493-5. PubMed ID: 15485326
    [No Abstract]   [Full Text] [Related]  

  • 8. Genomics and future biological weapons: the need for preventive action by the biomedical community.
    Fraser CM; Dando MR
    Nat Genet; 2001 Nov; 29(3):253-6. PubMed ID: 11687792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Difficulties associated with the development and licensing of vaccines for protection against bio-warfare and bio-terrorism.
    Langford MJ; Myers RC
    Dev Biol (Basel); 2002; 110():107-12. PubMed ID: 12477313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Bioterrorism - a challenge for public health services].
    Graf P
    Gesundheitswesen; 2004 Feb; 66 Suppl 1():S52-5. PubMed ID: 14770339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Biological security confronting bioterrorism].
    Suárez Fernández G
    An R Acad Nac Med (Madr); 2002; 119(1):77-89; discussion 89-95. PubMed ID: 12197209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunization against potential biological warfare agents.
    Cieslak TJ; Christopher GW; Kortepeter MG; Rowe JR; Pavlin JA; Culpepper RC; Eitzen EM
    Clin Infect Dis; 2000 Jun; 30(6):843-50. PubMed ID: 10880299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in detecting and responding to threats from bioterrorism and emerging infectious disease.
    Rotz LD; Hughes JM
    Nat Med; 2004 Dec; 10(12 Suppl):S130-6. PubMed ID: 15577931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Dengue fever: from disease to vaccination].
    Teyssou R
    Med Trop (Mars); 2009 Aug; 69(4):333-4. PubMed ID: 19725380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccination as a control strategy against the coccidial parasites Eimeria, Toxoplasma and Neospora.
    Innes EA; Vermeulen AN
    Parasitology; 2006; 133 Suppl():S145-68. PubMed ID: 17274844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccines for military use.
    Artenstein AW
    Vaccine; 2009 Nov; 27 Suppl 4():D16-22. PubMed ID: 19837279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccine immunology.
    Bartlett BL; Pellicane AJ; Tyring SK
    Dermatol Ther; 2009; 22(2):104-9. PubMed ID: 19335722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing the effectiveness and public health impact of rotavirus vaccines after introduction in immunization programs.
    Patel MM; Parashar UD
    J Infect Dis; 2009 Nov; 200 Suppl 1():S291-9. PubMed ID: 19817612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A personal glimpse of clinical infectious diseases: 1949-1999.
    Liu C
    J Microbiol Immunol Infect; 2001 Mar; 34(1):1-7. PubMed ID: 11321123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The new ACAM2000 vaccine and other therapies to control orthopoxvirus outbreaks and bioterror attacks.
    Handley L; Buller RM; Frey SE; Bellone C; Parker S
    Expert Rev Vaccines; 2009 Jul; 8(7):841-50. PubMed ID: 19538111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.